Cybersecurity experts are urging everyone to change their passwords after finding massive collection of 1.3 billion passwords ...
Corvus Pharmaceuticals, Inc. (NASDAQ: CRVS), a clinical-stage biopharmaceutical company, today announced that final data from its Phase 1/1b trial of soquelitinib in patients with T cell lymphoma will ...